An EUA is com­ing, FDA tells Pfiz­er

Just 12 hours af­ter an ad­vi­so­ry com­mit­tee over­whelm­ing­ly vot­ed to rec­om­mend the agency au­tho­rize Pfiz­er and BioN­Tech’s Covid-19 vac­cine, the FDA has in­formed both com­pa­nies that they are work­ing to is­sue a rapid EUA.

“Fol­low­ing yes­ter­day’s pos­i­tive ad­vi­so­ry com­mit­tee meet­ing out­come re­gard­ing the Pfiz­er-BioN­Tech COVID-19 vac­cine, the U.S. Food and Drug Ad­min­is­tra­tion has in­formed the spon­sor that it will rapid­ly work to­ward fi­nal­iza­tion and is­suance of an emer­gency use au­tho­riza­tion,” FDA com­mis­sion­er Stephen Hahn said in a state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER